• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $FTLF

    FitLife Brands Inc.

    Subscribe to $FTLF
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for FitLife Brands Inc.

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    See more ratings

    FitLife Brands Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • FitLife Brands Announces First Quarter Earnings Call

      OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

      5/5/25 3:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Board Transition

      Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

      4/28/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands to Present at Planet MicroCap Investor Conference

      OMAHA, NE, April 22, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 9:30 AM (Local Time - PST).  Dayton Judd, the Company's Chairman & CEO, and Ryan Hansen, the Company's Executive Vice President, will be hosting the presentation and answering questions at the conclusion. Investors can access the live presentation using the following information: Date: Wednesday, April 23, 2025Time: 9:30 AM (Las Vegas, NV Local Time PST)Webcast: https://event.summitcast.com/view/YNz6mnmEsXyrdRxb78w2nX/dWdauWRz32S

      4/22/25 7:29:59 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

      Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

      3/27/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces its Participation at the 37th Annual Roth Conference and Provides Financial and Operational Update

      Omaha, NE, March 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the 37th Annual Roth Conference on Monday and Tuesday, March 17-18, 2025.  Investors who are interested in meeting with FitLife management should submit their requests through their Roth representative. In conjunction with its participation in the conference, the Company has prepared an updated investor presentation which will be filed with the Securities and Exchange Commission on Form 8-K in advance of the conference.  The Company plans to repor

      3/13/25 8:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Fourth Quarter Earnings Call

      Omaha, NE, March 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the fourth quarter and full year of fiscal 2024 on Thursday, March 27, 2025. In addition, the Company announced that it will hold an investor conference call after market close on March 27, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 133626.  International participants can dial (973) 528-0163 and provide t

      3/7/25 9:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces 2-for-1 Forward Stock Split

      Omaha, NE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will be implementing a 2-for-1 forward stock split. The Company's common stock will begin trading on a split-adjusted basis on Friday, February 7, 2025. In conjunction with the stock split, the CUSIP number for Company's common stock will change to 33817P405. As of February 5, 2025, immediately prior to the forward stock split, there were 4,605,108 shares of the Company's common stock outstanding. Immediately following the forward stock split, there will be 9,210,216 sha

      2/5/25 5:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Responds to Investor Questions Regarding Registration Statement

      OMAHA, NE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today responds to questions from investors regarding its filing of a registration statement with the SEC. On Thursday, November 14th, 2024, the Company filed a shelf registration statement on Form S-3 with the SEC.  On its earnings call, the Company addressed the filing of the S-3.  In response to investor questions, the Company is repeating the information provided by management on the earnings call.  In his prepared remarks during the conference call, the Company's CEO, Dayton Judd, stated

      11/18/24 8:00:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Third Quarter 2024 Results

      Omaha, Nov. 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2024. Highlights for the third quarter ended September 30, 2024 include: Total revenue was $16.0 million, an increase of 15% compared to the third quarter of 2023.  Online sales were $10.8 million, representing 68% of total revenue and an increase of 14% compared to the third quarter of 2023.Gross margin was 43.8% compared to 41.0% during the third quarter of 2023.Net income was $2.1 million compared to $

      11/14/24 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Third Quarter Earnings Call

      OMAHA, NE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the third quarter of fiscal 2024 on Thursday, November 14, 2024. In addition, the Company announced that it will hold an investor conference call after market close on November 14, 2024 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 683771.  International participants can dial (973) 528-0163 and provide the sam

      11/6/24 11:00:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    FitLife Brands Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on FitLife Brands with a new price target

      Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

      3/17/25 8:22:47 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • ROTH MKM initiated coverage on FitLife Brands with a new price target

      ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

      9/3/24 7:48:49 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    FitLife Brands Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:05 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/2/25 8:01:06 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Ordal Todd bought $4,556 worth of shares (150 units at $30.37), increasing direct ownership by 0.48% to 31,094 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      1/16/25 6:12:18 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    FitLife Brands Inc. SEC Filings

    See more
    • Amendment: SEC Form 10-K/A filed by FitLife Brands Inc.

      10-K/A - FITLIFE BRANDS, INC. (0001374328) (Filer)

      4/28/25 6:43:29 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      4/28/25 8:00:11 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      4/22/25 7:30:15 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      3/27/25 2:38:37 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 10-K filed by FitLife Brands Inc.

      10-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      3/27/25 7:38:37 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      3/13/25 8:45:22 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      2/5/25 5:11:28 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      12/16/24 8:00:21 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by FitLife Brands Inc.

      EFFECT - FITLIFE BRANDS, INC. (0001374328) (Filer)

      11/21/24 12:15:04 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

      11/18/24 8:15:31 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    FitLife Brands Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Hansen Ryan P. claimed ownership of 25,678 shares (SEC Form 3)

      3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      5/12/25 7:27:11 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3 filed by new insider Pappas Shannon K.

      3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      5/12/25 7:26:27 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:05 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/2/25 8:01:06 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • CHIEF EXECUTIVE OFFICER Dayton Judd exercised 144,000 shares at a strike of $2.62, increasing direct ownership by 16% to 1,031,226 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/2/25 8:00:05 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Dawson Grant Robert was granted 2,144 shares, increasing direct ownership by 1% to 155,000 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      3/28/25 9:08:07 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Ordal Todd bought $4,556 worth of shares (150 units at $30.37), increasing direct ownership by 0.48% to 31,094 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      1/16/25 6:12:18 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • CHIEF EXECUTIVE OFFICER Dayton Judd exercised 6,200 shares at a strike of $0.70, increasing direct ownership by 1% to 443,613 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      1/2/25 4:30:14 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 4 filed by CHIEF FINANCIAL OFFICER York Jakob

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      9/3/24 4:20:03 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    FitLife Brands Inc. Leadership Updates

    Live Leadership Updates

    See more
    • FitLife Brands Announces Board Transition

      Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

      4/28/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • LifeVantage Appoints Dayton Judd to the Board of Directors

      SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

      2/15/24 4:05:00 PM ET
      $FTLF
      $LFVN
      $OPXS
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Electronic Components

    FitLife Brands Inc. Financials

    Live finance-specific insights

    See more
    • FitLife Brands Announces First Quarter Earnings Call

      OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

      5/5/25 3:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

      Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

      3/27/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Fourth Quarter Earnings Call

      Omaha, NE, March 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the fourth quarter and full year of fiscal 2024 on Thursday, March 27, 2025. In addition, the Company announced that it will hold an investor conference call after market close on March 27, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 133626.  International participants can dial (973) 528-0163 and provide t

      3/7/25 9:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Responds to Investor Questions Regarding Registration Statement

      OMAHA, NE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today responds to questions from investors regarding its filing of a registration statement with the SEC. On Thursday, November 14th, 2024, the Company filed a shelf registration statement on Form S-3 with the SEC.  On its earnings call, the Company addressed the filing of the S-3.  In response to investor questions, the Company is repeating the information provided by management on the earnings call.  In his prepared remarks during the conference call, the Company's CEO, Dayton Judd, stated

      11/18/24 8:00:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Third Quarter 2024 Results

      Omaha, Nov. 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2024. Highlights for the third quarter ended September 30, 2024 include: Total revenue was $16.0 million, an increase of 15% compared to the third quarter of 2023.  Online sales were $10.8 million, representing 68% of total revenue and an increase of 14% compared to the third quarter of 2023.Gross margin was 43.8% compared to 41.0% during the third quarter of 2023.Net income was $2.1 million compared to $

      11/14/24 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Third Quarter Earnings Call

      OMAHA, NE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the third quarter of fiscal 2024 on Thursday, November 14, 2024. In addition, the Company announced that it will hold an investor conference call after market close on November 14, 2024 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 683771.  International participants can dial (973) 528-0163 and provide the sam

      11/6/24 11:00:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Second Quarter 2024 Results

      Omaha, Aug. 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2024. Highlights for the second quarter ended June 30, 2024 include: Total revenue was $16.9 million, an increase of 15% compared to the second quarter of 2023.  Online sales were $11.2 million, representing 66% of total revenue and an increase of 13% compared to the second quarter of 2023.Gross margin was 44.8% compared to 40.4% during the second quarter of 2023.Net income was $2.6 million compared to $2.0 million during

      8/14/24 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Second Quarter Earnings Call

      Omaha. NE, Aug. 05, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the second quarter of fiscal 2024 on Wednesday, August 14, 2024. In addition, the Company announced that it will hold an investor conference call after market close on August 14, 2024 at 4:30 pm ET. Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 266347. International participants can dial (973) 528-0163 and provide the same code

      8/5/24 4:30:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces First Quarter 2024 Results

      Omaha, May 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2024. Highlights for the first quarter ended March 31, 2024 include: Total revenue was $16.5 million, an increase of 54% compared to the first quarter of 2023.  Online sales were $10.8 million, representing 65% of total revenue and an increase of 116% compared to the first quarter of 2023.Gross margin was 44.0% compared to 41.1% during the first quarter of 2023.Net income for the first quarter of 2024 was $2.2 million c

      5/14/24 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces First Quarter Earnings Call and its Participation at Sidoti Virtual Investor Conference and Provides Operational Update

      OMAHA, NE, May 08, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the Sidoti Virtual Investor Conference on Wednesday and Thursday, May 8-9, 2024.  The Company's presentation will begin at 1:45pm EDT on May 9, 2024, and can be accessed live at the following link: https://sidoti.zoom.us/webinar/register/WN_VDHnrzFZSqGQgICgizO8ew.  FitLife will also host virtual one-on-one meetings with investors on Wednesday and Thursday, May 8-9, 2024.  To register for the presentation or for a one-on-one meeting, please visit www.

      5/8/24 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care